PX1 Research supplies USA-manufactured, analytical-grade Glucagon-Like Peptide-1 (GLP-1) analogs for qualified academic and industrial laboratory applications. Every lot undergoes rigorous testing to verify high purity, chemical identity, and low endotoxin thresholds. Explore our analytical data, lot-specific COAs, and institutional procurement options below.
PX1 Research supplies USA-manufactured, analytical-grade Glucagon-Like Peptide-1 (GLP-1) analogs for qualified academic and industrial laboratory applications. Every lot undergoes rigorous testing to verify high purity, chemical identity, and low endotoxin thresholds. Explore our analytical data, lot-specific COAs, and institutional procurement options below.
To buy GLP-1 research peptide reagents for valid in vitro and preclinical research, institutional scientists require verifiable purity, lot-specific analytical reports, and reliable domestic manufacturing. PX1 Research provides high-purity, lyophilized GLP-1 research peptides synthesized in GMP-compliant facilities within the United States. Every batch undergoes third-party verification via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS) through an independent ISO 17025 accredited laboratory to confirm sequence fidelity and purity exceeding standard research thresholds.
Researchers evaluating vendor options must prioritize comprehensive quality documentation over basic catalog listings. Obtaining verified peptides ensures that experimental variance in cell culture assays or animal models stems from controlled biological variables rather than impurities, counter-ion contamination, or structural degradation. Browse our full catalog of all peptides or consult our research portal for detailed chemical specifications.
Glucagon-Like Peptide-1 (GLP-1) is a naturally occurring 30-amino-acid incretin peptide derived from the post-translational cleavage of proglucagon. In endogenous physiology, it is secreted primarily by intestinal L-cells in response to nutrient ingestion. Within laboratory setups, GLP-1 serves as the primary probe for evaluating the Glucagon-Like Peptide-1 Receptor (GLP-1R), a class B G-protein-coupled receptor (GPCR) predominantly expressed in pancreatic beta cells, the central nervous system, and cardiovascular tissues.
When GLP-1 binds to the extracellular domain of GLP-1R, it induces a conformational shift that activates intracellular adenylate cyclase. In vitro assays demonstrate that this activation elevates intracellular cyclic adenosine monophosphate (cAMP) concentrations, subsequently triggering protein kinase A (PKA) and exchange protein directly activated by cAMP (EPAC2) signaling cascades. In isolated pancreatic islet cell cultures, this mechanism enhances glucose-dependent insulin release while suppressing glucagon secretion from alpha cells.
Preclinical studies frequently utilize GLP-1 analogs to investigate broad metabolic, neuroprotective, and cell-survival pathways. In cell-based models of cellular stress, GLP-1R activation has been observed to attenuate apoptosis in beta cells by upregulating anti-apoptotic proteins such as Bcl-2 and modulating endoplasmic reticulum (ER) stress markers. Investigators studying metabolic signaling often utilize GLP-1 in co-culture models to measure differential gene expression related to lipid storage and glucose transport.
In rodent models of metabolic dysregulation, administration of stable GLP-1 receptor agonists provides insights into central appetite regulation and peripheral tissue sensitivity. Hypothalamic signaling studies indicate that GLP-1 binding within the arcuate nucleus modulates pro-opiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART) neuronal firing. These preclinical models allow researchers to map central satiety pathways and evaluate the secondary downstream effects of incretin signaling on systemic expenditure and cardiovascular hemodynamics.
The evolution of incretin biology has expanded beyond native GLP-1 sequences to include modified mono, dual, and triple receptor agonists designed for prolonged half-life and augmented signaling cascades. When selecting compounds for comparative baseline studies, researchers often evaluate native GLP-1 alongside synthetic analogs to benchmark target affinity, internalization kinetics, and receptor desensitization profiles.
For instance, mono-agonists such as semaglutide incorporate specific side-chain modifications to facilitate albumin binding and resist dipeptidyl peptidase-4 (DPP-4) enzymatic cleavage. Dual agonists like tirzepatide combine GLP-1R activity with Glucose-dependent Insulinotropic Polypeptide (GIP) receptor activation, whereas triple agonists like retatrutide add Glucagon Receptor (GCGR) agonism. Investigating these distinct chemical architectures allows research teams to map how co-activation of parallel metabolic pathways alters cellular respiration, signaling intensity, and gene expression compared to standard GLP-1 probes. For an in-depth mechanistic comparison, review our guide on GLP-1 receptor agonists overview.
Securing reliable data requires sourcing research compounds supported by complete analytical documentation. Every lot of GLP-1 research peptide supplied by PX1 Research is accompanied by a downloadable, lot-specific Certificate of Analysis (COA) issued by an independent ISO 17025 accredited testing facility. Researchers should critically evaluate these reports prior to initiating experimental assays.
High-Performance Liquid Chromatography (RP-HPLC) chromatograms confirm chemical purity by separating the primary peptide peak from shorter deletion sequences or chemical impurities. Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the precise molecular mass of the peptide, verifying that the correct amino acid sequence and modifications are present. Furthermore, endotoxin testing via the Limulus Amebocyte Lysate (LAL) assay ensures that bacterial lipopolysaccharides (LPS) remain below stringent thresholds (typically < 0.01 EU/μg), protecting sensitive cell culture protocols from non-specific inflammatory responses.
Lyophilized GLP-1 peptides require careful reconstitution to maintain structural integrity and biological activity. For standard in vitro work, reconstituting the peptide in sterile Bacteriostatic Water or sterile Phosphate-Buffered Saline (PBS, pH 7.4) is common practice, depending on the requirements of downstream assays. When reconstituting highly hydrophobic analogs, short exposure to dilute acetic acid (0.1%) or DMSO may be required prior to buffering.
To reconstitute, researchers should allow the sealed vial to reach room temperature before adding the solvent. Direct solvent onto the glass wall of the vial rather than directly onto the lyophilized cake. Gently swirl the vial until dissolved—never vortex or subject the solution to violent mechanical agitation, as shear forces can induce peptide aggregation or tertiary structure denaturing. For precise calculation of working concentrations, consult our interactive peptide reconstitution calculator guide.
Proper storage conditions are essential to preserve the stability of synthetic GLP-1 peptides over extended timelines. Lyophilized powders are stable at -20°C for up to 24 months, provided they are kept away from light and moisture. For long-term archiving (exceeding two years), storage at -80°C in desiccated containers is recommended to prevent hydrolytic degradation.
Once reconstituted into aqueous solutions, GLP-1 peptides exhibit reduced stability due to risk of hydrolysis, oxidation, and aggregation. Aliquoting reconstituted solutions into single-use, low-binding microcentrifuge tubes minimizes freeze-thaw cycles, which rapidly degrade peptide integrity. Reconstituted aliquots stored at -20°C or -80°C should generally be used within 3 to 6 months, while working solutions kept at 4°C should be utilized within 24 to 72 hours.
PX1 Research enforces strict compliance and quality control measures to support academic institutions, biotechnology firms, and contract research organizations (CROs). Our products are strictly designated for laboratory research use only and are not intended for human or veterinary applications. Procurement departments can rely on transparent lot traceability, standardized manufacturing documentation, and consistent batch-to-batch reproducibility.
Orders are processed directly from our climate-controlled facilities in California and Arizona, ensuring same-day dispatch for orders submitted Monday through Friday prior to standard cut-off times. Institutional accounts requiring bulk quantities, tailored vial sizing, or specialized packaging protocols can coordinate directly through our dedicated wholesale procurement team.
What is the certified purity level of PX1 Research's GLP-1 peptides?
All GLP-1 research peptides offered by PX1 Research are verified at ≥98% or ≥99% purity by independent ISO 17025 accredited laboratories using RP-HPLC testing.
How can I access the Certificate of Analysis (COA) for my specific lot?
Lot-specific COAs containing raw RP-HPLC chromatograms, mass spectrometry reports, and endotoxin assay data are available for download on our website using the lot number printed on your product vial.
Are PX1 Research peptides manufactured in the USA?
Yes. All PX1 Research peptides are synthesized in state-of-the-art, GMP-compliant facilities located within the United States.
What solvent is recommended for reconstituting GLP-1 for in vitro assays?
GLP-1 is typically reconstituted using sterile Bacteriostatic Water or sterile PBS (pH 7.4). If dissolution proves difficult due to hydrophobic properties, a small amount of dilute acetic acid (0.1%) or DMSO can be used prior to diluting with buffer.
What are the acceptable endotoxin limits for laboratory research peptides?
PX1 Research enforces strict endotoxin controls, ensuring levels remain well below standard cell-culture limits (typically <0.01 EU/μg) to prevent cellular toxicity or inflammatory interference in experimental assays.
How should reconstituted GLP-1 solutions be stored to prevent degradation?
Reconstituted solutions should be divided into single-use aliquots in low-binding microcentrifuge tubes and frozen at -20°C or -80°C. Repeated freeze-thaw cycles must be avoided.
How does native GLP-1 differ structurally from semaglutide or tirzepatide?
Native GLP-1 has a short biological half-life due to rapid cleavage by DPP-4 enzymes. Synthetic analogs such as semaglutide feature amino acid substitutions (e.g., Aib8) and fatty acid side chains to resist degradation, while tirzepatide incorporates dual GLP-1 and GIP receptor agonist structures.
Does PX1 Research support bulk or institutional ordering?
Yes. We offer institutional procurement services, bulk volume pricing, and custom synthesis options for verified research laboratories via our wholesale account portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.